Nvidia's (NVDA 0.87%) iron grip on AI chips faces a real challenger with Advanced Micro Devices' (AMD -0.20%). In this video, I compare the titans, break down the tech, and reveal who might rule the AI chip war over the next five years.

HOUSTON--(BUSINESS WIRE)--Phillips 66 released its 2025 Sustainability and People Report today.

URTH is overly concentrated in US equities, offering little true international diversification and closely mirroring S&P 500 performance at lower volatility. A simple 70% SPY + 30% cash or risk-free assets portfolio outperforms iShares MSCI World ETF on both returns and drawdown protection. For genuine global diversification, combining SPY with targeted ex-U.S. developed (IEFA) and emerging markets (VWO/IEMG) ETFs is a superior approach.

Clover's rapid value-added services adoption and product innovation are driving robust revenue growth, positioning Fiserv as an essential SMB operating system. New initiatives like Clover Hospitality, ADP partnership, and CashFlow Central expand Fiserv's addressable market and enhance monetization potential. International expansion is moving from plan to execution, leveraging local partnerships for capital-efficient, scalable growth, especially in Brazil and new markets.

The National Transportation Safety Board warned that certain CFM engines installed in some Boeing 737 Max jets may feed smoke into the cockpit or cabin after a bird strike.

NUE anticipates a second-quarter earnings jump, fueled by gains in its steel mills segment from stronger pricing.

AEM lifts gold reserves and inferred resources as drilling success fuels optimism for continued growth.

Add stability to your portfolio with KO, PM, MDLZ, MO, and CTVA as high-yield consumer staples poised for steady 2025 growth.

The shares of USDC stablecoin parent Circle Internet Group Inc (NYSE:CRCL) were last seen up 22.4% to trade at $182.50.

GREEN BAY, Wis.--(BUSINESS WIRE)--Safety isn't just a priority at Schneider; it's the cornerstone of the company's culture and operations. Today, Schneider National, Inc. (NYSE: SNDR), a premier multimodal provider of transportation, intermodal and logistics services, celebrates 220 drivers who have achieved unparalleled safety milestones, exemplifying its core value of Safety First and Always. Schneider drivers cumulatively travel over 9 million freight miles every day, ensuring essential good.

LOS ANGELES , June 18, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ: FTRE). IF YOU SUFFERED A LOSS ON YOUR FORTREA INVESTMENTS, CLICK HERE BEFORE AUGUST 1, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Civitas Resources, Inc. (NYSE: CIVI) between February 27, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), of the important July 1, 2025 lead plaintiff deadline.

Relatives of some of the 346 people killed in two Boeing 737 MAX crashes in 2018 and 2019 on Wednesday asked a federal judge to reject a deal between the Justice Department and the planemaker to allow the company to avoid prosecution in a fraud case.

Gilead Sciences Inc (NASDAQ:GILD, ETR:GIS)'s twice-yearly injectable HIV prevention drug lenacapavir is on track for a solid launch after being officially approved by the US Food and Drug Administration (FDA) on Wednesday, analysts at Jefferies believe. Lenacapavir, marketed as Yeztugo, is the first pre-exposure prophylaxis (PrEP) drug requiring only two treatments per year, offering a significant convenience advantage over daily oral PrEP and cabotegravir, which requires six injections per year.

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, in combination with rituximab and lenalidomide for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL). "Patients living with relapsed or refractory FL have been waiting for new options that improve progression-free survival without.

MADISON, N.J. , June 18, 2025 /PRNewswire/ -- Anywhere Real Estate Inc. ("Anywhere" or the "Company") (NYSE: HOUS) announced today that Anywhere Real Estate Group LLC (the "Issuer") and Anywhere Co-Issuer Corp. (the "Co-Issuer" and together with the Issuer, the "Issuers"), each a subsidiary of the Company, priced $500 million aggregate principal amount of 9.750% senior secured second lien notes due 2030 (the "Notes") at an issue price of 100.00% in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act").

AMLP offers direct exposure to US midstream operators with an attractive 8% yield, benefiting from stable, dividend-paying companies. The ETF recently increased its dividend and could reach a $1 payout, supporting a price target of $52.25–$53.33 if yields normalize. Key risks include sector concentration, potential declines in US oil and gas production, and sensitivity to dividend cuts or trade tensions.

IRVING, Texas, June 18, 2025 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living ®, the rental subsidiary of Toll Brothers, Inc. (NYSE: TOL), the nation's leading builder of luxury homes, and joint venture partner Carlyle announce the grand opening of Peregrine, a new luxury mid-rise apartment community near Dallas, Texas. Located at 6001 Love Drive in Irving, the community features 364 residences in a mix of studio, one-bedroom, and two-bedroom floor plans.

Aurora Cannabis reported mixed Q4/FY2025 results, with higher-than-expected revenues offset by lower profitability due to a number of one-time expenses. Following substantial growth in recent quarters, medical cannabis sales were essentially flat on a quarter-over-quarter basis. On the conference call, management admitted to headwinds from recent regulatory changes in Poland. As a result, medical cannabis sales and profitability are expected to decline in Q1/FY2026.

After two months of relative stability, new data from CarMax KMX Auto Finance (CAF) shows a renewed uptick in loan delinquencies and net losses, raising concerns about credit quality across the used auto lender's portfolio.